EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy.

Bao Y, Oguz G, Lee WC, Lee PL, Ghosh K, Li J, Wang P, Lobie PE, Ehmsen S, Ditzel HJ, Wong A, Tan EY, Lee SC, Yu Q
Nat Commun. 2020 Nov 18;11(1):5878. doi: 10.1038/s41467-020-19704-x. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.